{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:33:12Z","timestamp":1792715592408,"version":"4.5.0"},"reference-count":229,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"vor","delay-in-days":248,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective:<\/jats:title><jats:p>To develop clinical practice guidelines for the management of patients with primary aldosteronism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants:<\/jats:title><jats:p>The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guideline was cosponsored by American Heart Association, American Association of Endocrine Surgeons, European Society of Endocrinology, European Society of Hypertension, International Association of Endocrine Surgeons, International Society of Endocrinology, International Society of Hypertension, Japan Endocrine Society, and The Japanese Society of Hypertension. The Task Force received no corporate funding or remuneration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Evidence:<\/jats:title><jats:p>We searched for systematic reviews and primary studies to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation group criteria to describe both the quality of evidence and the strength of recommendations. We used \u201crecommend\u201d for strong recommendations and \u201csuggest\u201d for weak recommendations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Consensus Process:<\/jats:title><jats:p>We achieved consensus by collecting the best available evidence and conducting one group meeting, several conference calls, and multiple e-mail communications. With the help of a medical writer, the Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and Council successfully reviewed the drafts prepared by the Task Force. We placed the version approved by the Clinical Guidelines Subcommittee and Clinical Affairs Core Committee on the Endocrine Society's website for comments by members. At each stage of review, the Task Force received written comments and incorporated necessary changes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions and recommend that a commonly used confirmatory test should confirm\/exclude the condition. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend that an experienced radiologist should establish\/exclude unilateral primary aldosteronism using bilateral adrenal venous sampling, and if confirmed, this should optimally be treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia or those unsuitable for surgery should be treated primarily with a mineralocorticoid receptor antagonist.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2015-4061","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T18:01:29Z","timestamp":1456941689000},"page":"1889-1916","source":"Crossref","is-referenced-by-count":2640,"title":["The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline"],"prefix":"10.1210","volume":"101","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[{"name":"Hudson Institute of Medical Research (J.W.F.), Clayton, VIC 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Carey","sequence":"additional","affiliation":[{"name":"University of Virginia Health System (R.M.C.), Charlottesville, Virginia 22908"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Mantero","sequence":"additional","affiliation":[{"name":"University of Padova (F.M.), 35122 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Klinikum of the Ludwig-Maximilians-University of Munich (M.R.), 80366 M\u00fcnchen, Bavaria, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Oita University (H.S.), Oita 870-1124, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[{"name":"University of Queensland (M.S.), Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William F.","family":"Young","sequence":"additional","affiliation":[{"name":"Mayo Clinic (W.F.Y.), Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614225531900_B1","unstructured":"Institute of Medicine, National Academy of Sciences. Standards for developing trustworthy clinical practice guidelines. http:\/\/www.iom.edu\/Reports\/2011\/Clinical-Practice-Guidelines-We-Can-Trust\/Standards.aspx. Accessed January 8, 2015Updated August 19, 2015."},{"key":"2020071614225531900_B2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"2020071614225531900_B3","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajh\/hpu154","article-title":"Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies","volume":"28","author":"Marzano","year":"2015","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient's cohorts and in population-based studies\u2013a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"2020071614225531900_B7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"2020071614225531900_B8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614225531900_B9","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"2020071614225531900_B10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic primary aldosteronism. A detectable cause of curable \u201cessential\u201d hypertension","volume":"193","author":"Conn","year":"1965","journal-title":"JAMA"},{"key":"2020071614225531900_B11","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954\u20131967","volume":"62","author":"Conn","year":"1966","journal-title":"Harvey Lect"},{"key":"2020071614225531900_B12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"key":"2020071614225531900_B13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","article-title":"Incidence of primary aldosteronism uncomplicated \u201cessential\u201d hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria","volume":"205","author":"Fishman","year":"1968","journal-title":"JAMA"},{"key":"2020071614225531900_B14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/bmj.2.6035.554","article-title":"Prevalence of primary and secondary hypertension: studies in a random population sample","volume":"2","author":"Berglund","year":"1976","journal-title":"Br Med J"},{"key":"2020071614225531900_B15","first-page":"549","article-title":"Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975","volume":"52","author":"Tucker","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"2020071614225531900_B16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","article-title":"Reliability of screening methods for the diagnosis of primary aldosteronism","volume":"67","author":"Streeten","year":"1979","journal-title":"Am J Med"},{"key":"2020071614225531900_B17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B18","first-page":"187","article-title":"The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977\u20131981","volume":"2","author":"Andersen","year":"1988","journal-title":"J Hum Hypertens"},{"key":"2020071614225531900_B19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071614225531900_B20","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2020071614225531900_B21","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.1977.03270400035014","article-title":"Diagnosis of secondary forms of hypertension. A comprehensive protocol","volume":"237","author":"Grim","year":"1977","journal-title":"JAMA"},{"key":"2020071614225531900_B22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1681.1985.tb02641.x","article-title":"Is aldosterone\/renin ratio useful to screen a hypertensive population for primary aldosteronism?","volume":"12","author":"Hamlet","year":"1985","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071614225531900_B23","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"2020071614225531900_B25","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"2020071614225531900_B28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin Chem"},{"key":"2020071614225531900_B29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071614225531900_B30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2020071614225531900_B31","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"2020071614225531900_B33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"2020071614225531900_B34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"2020071614225531900_B35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"2020071614225531900_B36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"2020071614225531900_B37","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","article-title":"Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone","volume":"28","author":"Ori","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2020071614225531900_B38","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B39","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"2020071614225531900_B40","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"key":"2020071614225531900_B41","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B42","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism","volume":"73","author":"McKenna","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"2020071614225531900_B44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"2020071614225531900_B45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ajh\/3.5.360","article-title":"Effect of age on response of secondary hypertension to specific treatment","volume":"3","author":"Streeten","year":"1990","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B46","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1373\/clinchem.2010.146449","article-title":"Plasma renin activity by LC-MS\/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity","volume":"56","author":"Bystrom","year":"2010","journal-title":"Clin Chem"},{"key":"2020071614225531900_B47","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","article-title":"Validity of the aldosterone-renin ratio used to screen for primary aldosteronism","volume":"76","author":"Montori","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"2020071614225531900_B48","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin Chem"},{"key":"2020071614225531900_B49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchromb.2014.08.042","article-title":"Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS\/MS and comparison with commercial immunoassays","volume":"970","author":"Ray","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2020071614225531900_B50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin Chem"},{"key":"2020071614225531900_B51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614225531900_B52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism\u2013careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2020071614225531900_B53","first-page":"865","article-title":"Primary aldosteronism and other forms of mineralocorticoid hypertension","volume-title":"Textbook of Hypertension","author":"Gordon","year":"1994"},{"key":"2020071614225531900_B54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","article-title":"The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling","volume":"90","author":"Tiu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00019616-199707040-00003","article-title":"Primary aldosteronism: update on diagnosis and treatment","volume":"7","author":"Young","year":"1997","journal-title":"Endocrinologist"},{"key":"2020071614225531900_B56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2020071614225531900_B57","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"Giacchetti","year":"2006","journal-title":"J Hypertens"},{"key":"2020071614225531900_B58","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/HJH.0b013e328126856e","article-title":"Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma","volume":"25","author":"Rossi","year":"2007","journal-title":"J Hypertens"},{"key":"2020071614225531900_B59","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","article-title":"Captopril test can give misleading results in patients with suspect primary aldosteronism","volume":"50","author":"Mulatero","year":"2007","journal-title":"Hypertension"},{"key":"2020071614225531900_B60","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/jc.2011-2504","article-title":"Confirmatory testing in primary aldosteronism","volume":"97","author":"Nanba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0032-1314786","article-title":"Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism","volume":"44","author":"Willenberg","year":"2012","journal-title":"Horm Metab Res"},{"key":"2020071614225531900_B62","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","article-title":"Comparison of confirmatory tests for the diagnosis of primary aldosteronism","volume":"91","author":"Mulatero","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","article-title":"Confirmatory tests in the diagnosis of primary aldosteronism","volume":"42","author":"Mulatero","year":"2010","journal-title":"Horm Metab Res"},{"key":"2020071614225531900_B64","first-page":"1157","article-title":"Screening tests and diagnostic examinations of hypertensives for primary aldosteronism [in Japanese]","volume":"54","author":"Omura","year":"2006","journal-title":"Rinsho Byori"},{"key":"2020071614225531900_B65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"2020071614225531900_B66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-11-0914","article-title":"Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients","volume":"166","author":"Solar","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071614225531900_B67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","article-title":"Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia","volume":"20","author":"Williams","year":"2006","journal-title":"J Hum Hypertens"},{"key":"2020071614225531900_B68","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/jc.2002-021476","article-title":"Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism","volume":"88","author":"Tanabe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B69","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","article-title":"Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives","volume":"86","author":"Hirohara","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B70","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma","volume":"26","author":"Letavernier","year":"2008","journal-title":"J Hypertens"},{"key":"2020071614225531900_B71","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B72","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"2020071614225531900_B73","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B74","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12672-011-0089-z","article-title":"Conventional imaging in adrenocortical carcinoma: update and perspectives","volume":"2","author":"Young","year":"2011","journal-title":"Horm Cancer"},{"key":"2020071614225531900_B75","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071614225531900_B76","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"2020071614225531900_B77","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"key":"2020071614225531900_B78","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1148\/rg.25si055514","article-title":"Adrenal vein sampling: how to make it quick, easy, and successful","volume":"25","author":"Daunt","year":"2005","journal-title":"Radiographics"},{"key":"2020071614225531900_B79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0960-0760(01)00097-8","article-title":"Familial hyperaldosteronism","volume":"78","author":"Stowasser","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071614225531900_B80","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med"},{"key":"2020071614225531900_B81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","article-title":"Long-term follow-up after adrenalectomy for primary aldosteronism","volume":"29","author":"Meyer","year":"2005","journal-title":"World J Surg"},{"key":"2020071614225531900_B82","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archinte.1967.00300040052009","article-title":"Primary aldosteronism","volume":"120","author":"Gunnells","year":"1967","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B83","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00000658-196805000-00010","article-title":"Primary aldosteronism: experience with current diagnostic criteria and surgical treatment in fourteen patients","volume":"167","author":"Rhamy","year":"1968","journal-title":"Ann Surg"},{"key":"2020071614225531900_B84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","article-title":"Primary aldosteronism: diagnosis, localization, and treatment","volume":"90","author":"Weinberger","year":"1979","journal-title":"Ann Intern Med"},{"key":"2020071614225531900_B85","first-page":"203","article-title":"Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism","volume":"27","author":"Baer","year":"1970","journal-title":"Circ Res"},{"key":"2020071614225531900_B86","first-page":"761","article-title":"Primary aldosteronism: surgical management and pathologic findings","volume":"43","author":"Priestley","year":"1968","journal-title":"Mayo Clin Proc"},{"key":"2020071614225531900_B87","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","article-title":"Primary aldosteronism. Diagnostic evaluation","volume":"17","author":"Young","year":"1988","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614225531900_B88","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","article-title":"Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases","volume":"86","author":"Rossi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B89","first-page":"101","article-title":"Diagnostic investigations in primary aldosteronism","volume-title":"Clinical Medicine Series on Hypertension","author":"Gordon","year":"2001"},{"key":"2020071614225531900_B90","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","article-title":"Hyperaldosteronism: sampling the adrenal veins","volume":"198","author":"Doppman","year":"1996","journal-title":"Radiology"},{"key":"2020071614225531900_B91","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn's registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"key":"2020071614225531900_B92","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2007.092080","article-title":"Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism","volume":"53","author":"Mengozzi","year":"2007","journal-title":"Clin Chem"},{"key":"2020071614225531900_B93","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0b013e3181961d77","article-title":"Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism","volume":"249","author":"Auchus","year":"2009","journal-title":"Ann Surg"},{"key":"2020071614225531900_B94","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jvir.2011.05.005","article-title":"Intraprocedural cortisol levels in the evaluation of proper catheter placement in adrenal venous sampling","volume":"22","author":"Reardon","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"2020071614225531900_B95","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ecl.2011.01.005","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"40","author":"Rossi","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614225531900_B96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-11-0287","article-title":"Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates","volume":"165","author":"Betz","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2020071614225531900_B97","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1530\/EC-13-0063","article-title":"Efficacy of adrenal venous sampling is increased by point of care cortisol analysis","volume":"2","author":"Viste","year":"2013","journal-title":"Endocr Connect"},{"key":"2020071614225531900_B98","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00268-005-0622-8","article-title":"Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas","volume":"30","author":"Tan","year":"2006","journal-title":"World J Surg"},{"key":"2020071614225531900_B99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1507\/endocrj.K07E-164","article-title":"Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism","volume":"55","author":"Minami","year":"2008","journal-title":"Endocr J"},{"key":"2020071614225531900_B100","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1210\/jc.2013-3789","article-title":"Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism","volume":"99","author":"Riester","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B101","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cen.12374","article-title":"Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling","volume":"81","author":"Sze","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614225531900_B103","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"2020071614225531900_B105","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.clinbiochem.2013.04.004","article-title":"Adrenal vein sampling: substantial need for technical improvement at regional referral centres","volume":"46","author":"Elliott","year":"2013","journal-title":"Clin Biochem"},{"key":"2020071614225531900_B106","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/01.RVI.0000134495.26900.6A","article-title":"Comparison of sequential versus simultaneous methods of adrenal venous sampling","volume":"15","author":"Carr","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"2020071614225531900_B107","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.111.189548","article-title":"Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism","volume":"59","author":"Monticone","year":"2012","journal-title":"Hypertension"},{"key":"2020071614225531900_B108","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1245\/s10434-011-2121-5","article-title":"What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?","volume":"19","author":"Webb","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2020071614225531900_B109","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cen.12761","article-title":"Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism","volume":"83","author":"Umakoshi","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614225531900_B110","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1210\/jc.2014-3676","article-title":"Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study","volume":"100","author":"Wolley","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B111","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","article-title":"What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?","volume":"70","author":"Young","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071614225531900_B112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"2020071614225531900_B113","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jcem-36-2-401","article-title":"Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma","volume":"36","author":"Ganguly","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B114","first-page":"S103","article-title":"Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension","volume":"5","author":"Gordon","year":"1987","journal-title":"J Hypertens Suppl"},{"key":"2020071614225531900_B115","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2002-022051","article-title":"Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling","volume":"88","author":"Espiner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B116","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","article-title":"Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma","volume":"85","author":"Phillips","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B117","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archinte.1972.00320030037002","article-title":"Primary aldosteronism. Photoscanning of tumors after administration of 131 I-19-iodocholesterol","volume":"129","author":"Conn","year":"1972","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B118","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem-45-2-353","article-title":"A new and superior adrenal imaging agent, 131I-6\u03b2-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans","volume":"45","author":"Sarkar","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B119","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM197602192940802","article-title":"Location of aldosterone-producing adenomas with 131I-19-iodocholesterol","volume":"294","author":"Hogan","year":"1976","journal-title":"N Engl J Med"},{"key":"2020071614225531900_B120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-71-4-825","article-title":"Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity","volume":"71","author":"Nomura","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B121","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-7061(01)02312-3","article-title":"Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning","volume":"15","author":"Mansoor","year":"2002","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B122","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/jcem-49-1-87","article-title":"The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism","volume":"49","author":"Biglieri","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B123","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-Hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"Mulatero","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B124","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1210\/jc.2010-2785","article-title":"18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism","volume":"96","author":"Nakamura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B125","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"2020071614225531900_B126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B127","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.crd.0000096417.42861.ce","article-title":"Glucocorticoid-remediable aldosteronism","volume":"12","author":"McMahon","year":"2004","journal-title":"Cardiol Rev"},{"key":"2020071614225531900_B128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"key":"2020071614225531900_B129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","article-title":"Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood","volume":"138","author":"Dluhy","year":"2001","journal-title":"J Pediatr"},{"key":"2020071614225531900_B130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"2020071614225531900_B131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 \u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"2020071614225531900_B132","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension","volume":"207","author":"Jonsson","year":"1995","journal-title":"Biochem Biophys Res Comm"},{"key":"2020071614225531900_B133","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1210\/jcem.86.10.7920","article-title":"Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1\/CYP11B2 gene","volume":"86","author":"Fardella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B134","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.jhh.1001152","article-title":"Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?","volume":"15","author":"Gates","year":"2001","journal-title":"J Hum Hypertens"},{"key":"2020071614225531900_B135","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","article-title":"Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity","volume":"23","author":"So","year":"2005","journal-title":"J Hypertens"},{"key":"2020071614225531900_B136","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071614225531900_B137","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"2020071614225531900_B138","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human Mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B139","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"2020071614225531900_B140","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614225531900_B141","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3904\/kjim.2005.20.4.303","article-title":"Clinical study of adrenal incidentaloma in Korea","volume":"20","author":"Kim","year":"2005","journal-title":"Korean J Intern Med"},{"key":"2020071614225531900_B142","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"2020071614225531900_B143","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"\u00c5kerstr\u00f6m","year":"2012","journal-title":"PLoS One"},{"key":"2020071614225531900_B144","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B145","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B146","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"2020071614225531900_B147","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"2020071614225531900_B148","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"2020071614225531900_B149","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1210\/jc.2006-0101","article-title":"Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism","volume":"91","author":"Rizzoni","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0895-7061(02)03021-2","article-title":"Left ventricular changes in primary aldosteronism","volume":"16","author":"Rossi","year":"2003","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B151","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B152","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"2020071614225531900_B153","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"2020071614225531900_B154","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"key":"2020071614225531900_B155","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure","volume":"56","author":"Tsuchiya","year":"2009","journal-title":"Endocr J"},{"key":"2020071614225531900_B156","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B157","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071614225531900_B158","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"2020071614225531900_B159","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1507\/endocrj.EJ13-0353","article-title":"Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study","volume":"61","author":"Miyake","year":"2014","journal-title":"Endocr J"},{"key":"2020071614225531900_B161","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-121-11-199412010-00010","article-title":"Diagnosis and treatment of primary hyperaldosteronism","volume":"121","author":"Blumenfeld","year":"1994","journal-title":"Ann Intern Med"},{"key":"2020071614225531900_B162","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0748-7983(03)00051-9","article-title":"Review of surgical management of aldosterone secreting tumours of the adrenal cortex","volume":"29","author":"Harris","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"2020071614225531900_B163","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B164","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1994.tb02520.x","article-title":"Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness","volume":"21","author":"Stowasser","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071614225531900_B165","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism\u2013changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"2020071614225531900_B166","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000658-199608000-00003","article-title":"Primary aldosteronism. Results of surgical treatment","volume":"224","author":"Lo","year":"1996","journal-title":"Ann Surg"},{"key":"2020071614225531900_B167","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/msy.1998.93108","article-title":"Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?","volume":"124","author":"Proye","year":"1998","journal-title":"Surgery"},{"key":"2020071614225531900_B168","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2020071614225531900_B169","first-page":"1995","article-title":"Laparoscopic versus open adrenalectomy for surgical adrenal disease","volume":"10","author":"Jacobsen","year":"2003","journal-title":"Can J Urol"},{"key":"2020071614225531900_B170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s002689900115","article-title":"Laparoscopic adrenalectomy","volume":"20","author":"Rutherford","year":"1996","journal-title":"World J Surg"},{"key":"2020071614225531900_B171","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","article-title":"Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"174","author":"Ishidoya","year":"2005","journal-title":"J Urol"},{"key":"2020071614225531900_B172","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071614225531900_B173","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","article-title":"Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism","volume":"89","author":"Sywak","year":"2002","journal-title":"Br J Surg"},{"key":"2020071614225531900_B174","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.surg.2010.09.012","article-title":"The management of aldosterone-producing adrenal adenomas\u2013does adrenalectomy increase costs?","volume":"148","author":"Reimel","year":"2010","journal-title":"Surgery"},{"key":"2020071614225531900_B175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"2020071614225531900_B176","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2012-2234","article-title":"Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy","volume":"97","author":"Fischer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B177","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"2020071614225531900_B178","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"2020071614225531900_B179","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"2020071614225531900_B180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.5816.729","article-title":"Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin","volume":"2","author":"Brown","year":"1972","journal-title":"Br Med J"},{"key":"2020071614225531900_B181","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00000441-197012000-00001","article-title":"Effect of spironolactone in hypertensive patients","volume":"260","author":"Crane","year":"1970","journal-title":"Am J Med Sci"},{"key":"2020071614225531900_B182","article-title":"Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications","volume-title":"Systemic Effects of Antihypertensive Agents","author":"Ganguly","year":"1976"},{"key":"2020071614225531900_B183","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","article-title":"Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading","volume":"58","author":"Helber","year":"1980","journal-title":"Klin Wochenschr"},{"key":"2020071614225531900_B184","doi-asserted-by":"crossref","first-page":"V115","DOI":"10.1161\/01.HYP.5.6_Pt_3.V115","article-title":"Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism","volume":"5","author":"Kater","year":"1983","journal-title":"Hypertension"},{"key":"2020071614225531900_B185","first-page":"213s","article-title":"Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes","volume":"45","author":"Kremer","year":"1973","journal-title":"Clin Sci Mol Med Suppl"},{"key":"2020071614225531900_B186","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1055\/s-2008-1070723","article-title":"Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome [in German]","volume":"105","author":"Wambach","year":"1980","journal-title":"Dtsch Med Wochenschr"},{"key":"2020071614225531900_B187","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2020071614225531900_B188","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"2020071614225531900_B189","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3565(25)22580-0","article-title":"Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro","volume":"240","author":"de Gasparo","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071614225531900_B190","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/S0149-2918(03)80282-5","article-title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","volume":"25","author":"Burgess","year":"2003","journal-title":"Clin Ther"},{"key":"2020071614225531900_B191","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"2020071614225531900_B192","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2020071614225531900_B193","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"2020071614225531900_B194","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J Hypertens"},{"key":"2020071614225531900_B195","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"2020071614225531900_B196","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/heart.88.5.475","article-title":"Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure","volume":"88","author":"Farquharson","year":"2002","journal-title":"Heart"},{"key":"2020071614225531900_B197","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2020071614225531900_B198","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B199","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","journal-title":"Pediatrics"},{"key":"2020071614225531900_B201","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2011.01.012","article-title":"Glucocorticoid-remediable aldosteronism","volume":"40","author":"Halperin","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071614225531900_B202","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","article-title":"Racial differences in sensitivity of blood pressure to aldosterone","volume":"63","author":"Tu","year":"2014","journal-title":"Hypertension"},{"key":"2020071614225531900_B203","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"2020071614225531900_B204","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2012.04.026","article-title":"Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2020071614225531900_B205","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","article-title":"2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension","volume":"21","author":"Whitworth","year":"2003","journal-title":"J Hypertens"},{"key":"2020071614225531900_B206","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"2020071614225531900_B207","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B208","first-page":"17","article-title":"Normokalemic hyperaldosteronism in patients with resistant hypertension","volume":"4","author":"Benchetrit","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"2020071614225531900_B209","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"2020071614225531900_B210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.HYP.0000116223.97436.e5","article-title":"Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"2020071614225531900_B211","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1378\/chest.125.1.112","article-title":"Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea","volume":"125","author":"Calhoun","year":"2004","journal-title":"Chest"},{"key":"2020071614225531900_B212","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0022-5347(17)37601-2","article-title":"A survey on incidental adrenal tumors in Japan","volume":"147","author":"Aso","year":"1992","journal-title":"J Urol"},{"key":"2020071614225531900_B213","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2796.2002.01028.x","article-title":"Adrenal incidentaloma\u2013experience of a standardized diagnostic programme in the Swedish prospective study","volume":"252","author":"B\u00fclow","year":"2002","journal-title":"J Intern Med"},{"key":"2020071614225531900_B214","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archsurg.1994.01420270067016","article-title":"Subclinical hormone secretion by incidentally discovered adrenal masses","volume":"129","author":"Caplan","year":"1994","journal-title":"Arch Surg"},{"key":"2020071614225531900_B215","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B216","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2020071614225531900_B217","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/jhh.2011.47","article-title":"Resistant hypertension, obstructive sleep apnoea and aldosterone","volume":"26","author":"Dudenbostel","year":"2012","journal-title":"J Hum Hypertens"},{"key":"2020071614225531900_B218","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2020071614225531900_B219","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"2020071614225531900_B220","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","article-title":"Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071614225531900_B221","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem"},{"key":"2020071614225531900_B222","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin Biochem"},{"key":"2020071614225531900_B223","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2006.03.034","article-title":"Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry","volume":"372","author":"Guo","year":"2006","journal-title":"Clin Chim Acta"},{"key":"2020071614225531900_B224","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension"},{"key":"2020071614225531900_B225","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1971.00310210056004","article-title":"Saline suppression of plasma aldosterone in hypertension","volume":"128","author":"Kem","year":"1971","journal-title":"Arch Intern Med"},{"key":"2020071614225531900_B226","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(94)93003-1","article-title":"Mineralocorticoid hypertension","volume":"344","author":"Gordon","year":"1994","journal-title":"Lancet"},{"key":"2020071614225531900_B227","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","article-title":"Captopril suppression versus salt loading in confirming primary aldosteronism","volume":"37","author":"Agharazii","year":"2001","journal-title":"Hypertension"},{"key":"2020071614225531900_B228","doi-asserted-by":"crossref","first-page":"289s","DOI":"10.1042\/cs061289s","article-title":"Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism","volume":"61","author":"Mantero","year":"1981","journal-title":"Clin Sci (Lond)"},{"key":"2020071614225531900_B229","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.1992.tb02252.x","article-title":"Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism","volume":"36","author":"Hambling","year":"1992","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/5\/1889\/20287850\/jcem1889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/5\/1889\/20287850\/jcem1889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T16:05:29Z","timestamp":1748793929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/5\/1889\/2804729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":229,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2015-4061","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}